Head-to-head · WeighScore
NuDay Rx vs RxPepsDirect
The verdict
RxPepsDirect takes it — 68.7/100 to 66.9/100, but only just.
RxPepsDirect grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxPepsDirect (Peptide RX LLC) is a per-vial compounded GLP-1 telehealth platform whose advertised vial prices are not the whole cost: a flat medical visit charge and flat overnight delivery are added to… NuDay Rx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NuDay Rx | RxPepsDirect |
|---|---|---|
| WeighScore | 66.9/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #175 | #140 |
| Semaglutide | $249/mo (compounded) | $79/mo (starting dose, visit fee and shipping included, compounded) |
| Tirzepatide | $329/mo (compounded) | $99/mo (starting dose, visit fee and shipping included, compounded) |
| Coverage | Coverage not published | 28 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #175 · C
Strengths
- Wide selection — compounded semaglutide ($249) and tirzepatide ($329), oral tablet options, plus brand GLP-1 (cash pay)
- Includes video coaching and lifestyle support with a licensed-doctor consult
- Full legal suite published (Terms, Privacy, Privacy Practices, Medical Consent)
- Prescription delivered to your door after an online intake and consult
Where it loses points
- Compounded semaglutide ($249) is pricier than some budget competitors
- Compounding pharmacy partner not named
- Not LegitScript-certified (no certification displayed)
- Runs on a shared white-label telehealth platform (CareValidate/careGLP)
Graded #140 · C
Strengths
- Every component of the price is published on the site — the vial tiers, the flat visit charge and the flat overnight delivery — so the all-in monthly cost can be worked out before ordering
- No subscription and no commitment: you pay per order, and one visit charge covers up to three peptides on the same prescription
- Real 503A telehealth Rx — licensed NP/PA prescribers under medical director Dr. Jonathan Snipes (NPI 1821250077), dispensed by Optimal Balance Pharmacy, Texas Board #34829
- Independent batch COA testing by Eagle Analytical (FDA-registered, A2LA ISO 17025): 54/54 sterility and endotoxin passes published publicly
- Ships pre-reconstituted by FedEx overnight with syringes, alcohol wipes and a reusable cooled travel case included
Where it loses points
- The advertised vial price is not the monthly cost: a flat $39 medical visit charge and $15 flat FedEx shipping land on every order, and the visit charge recurs on every reorder rather than once
- Higher doses need more than one vial a month and the site publishes no price for the dose you titrate up to, so the figure above is a floor
- Minimal clinical oversight: a roughly two-minute asynchronous intake, no live video consult, no labs required and no published dose-escalation monitoring
- No LegitScript certification, and the company was founded in 2026 with no public track record or outcomes data
- Only 28 states and DC — California is excluded, along with most of the Southeast (AL, AR, GA, MS, NC, SC, TN, VA)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.